Mebanazine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Mebanazine
Mebanazine.svg
Systematic (IUPAC) name
1-phenylethylhydrazine
Clinical data
Legal status
  • Prescription only
Routes Oral
Identifiers
CAS number 65-64-5
ATC code None
PubChem CID 6179
ChemSpider 5944
UNII Z5R55CJ4CG YesY
ChEMBL CHEMBL1909283
Chemical data
Formula C8H12N2 
Mol. mass 136.19 g/mol

Mebanazine (trade name Actomol) is a monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class that was previously used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]

See also[edit]

References[edit]

  1. ^ Gilmour SJ (September 1965). "Clinical trial of mebanazine--a new monoamine oxidase inhibitor". The British Journal of Psychiatry : the Journal of Mental Science 111 (478): 899–902. PMID 5889715. 
  2. ^ Barker JC, Jan IA, Enoch MD (November 1965). "A controlled trial of mebanazine ('Actomol') in depression". The British Journal of Psychiatry : the Journal of Mental Science 111 (480): 1095–100. PMID 5320546. 
  3. ^ Knott F (1965). "A preliminary trial of mebanazine in depressive states". The Journal of New Drugs 5 (6): 345–7. PMID 5327282.